🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the safety, efficacy and tolerabi...
Status
Completed
Location
Multiple Locations
Start Date
2008-10
Trial ID
NCT00703118
Treatments Being Tested
This is a multi-site, open-label trial evaluating the safety and efficacy o...
Status
Completed
Location
Multiple Locations
Start Date
2013-10-01
Trial ID
NCT01932762
Treatments Being Tested
The purpose of this study is to determine if concentration-controlled ribav...
Status
Completed
Location
University of Colorado Denver
Start Date
2010-02
Trial ID
NCT01097395
Treatments Being Tested
This is a non-randomized, open-label study examining the safety and efficac...
Status
Terminated
Location
University of Nebraska Medical Center
Start Date
2009-05-01
Trial ID
NCT00882193
Treatments Being Tested
The results of antiviral therapy in patients with recurrent hepatitis C aft...
Status
Completed
Location
Sapienza University of Rome
Start Date
2009-10
Trial ID
NCT00993122
Treatments Being Tested
The study aims to study the outcome of pharmacokinetics-adjusted dose ribav...
Status
Completed
Location
King Faisal Specialist Hospital & Research Centre
Start Date
2011-01
Trial ID
NCT01686789
Treatments Being Tested
This sudy will determine whether shortening treatment for hepatitis C is fe...
Status
Completed
Location
Hunter Pharmacotherapy
Start Date
2012-06
Trial ID
NCT01364090
Treatments Being Tested
To assess efficacy of telaprevir, pegylated interferon alfa-2a (Peg-IFN-alf...
Status
Terminated
Location
Alabama
Start Date
2012-02
Trial ID
NCT01467505
Treatments Being Tested
The purpose of this study is to determine if the combination treatment of C...
Status
Completed
Location
Scripps Clinic
Start Date
2010-01
Trial ID
NCT01051921
Treatments Being Tested
Drug users account for a disproportionately large burden of hepatitis C vir...
Status
Completed
Location
Albert Einstein College of Medicine Division of Substance Abuse
Start Date
2007-10
Trial ID
NCT01442311